Bionano Genomics Inc. Revenue 2017–2025
Bionano Genomics Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bionano Genomics Inc. revenue for the quarter ending March 31, 2026 was 6.7 M, a 3.56% increase year-over-year.
- Bionano Genomics Inc. revenue for the twelve months ending March 31, 2026 was 27.2 M, a 14.68% decrease year-over-year.
- Bionano Genomics Inc. annual revenue for 2025 was 28.5 M, a 7.37% decrease from 2024.
- Bionano Genomics Inc. annual revenue for 2024 was 30.8 M, a 14.79% decrease from 2023.
- Bionano Genomics Inc. annual revenue for 2023 was 36.1 M, a 29.90% increase from 2022.
- Bionano Genomics Inc. annual revenue for 2022 was 27.8 M.
Bionano Genomics Inc. (BNGO) — Frequently Asked Questions
Bionano Genomics Inc. (BNGO) is a publicly traded US company. It has a market capitalization of $6M. In fiscal 2025 it reported revenue of $29M and net income of -$26M. Explore BNGO's stock price, financial statements, earnings history, margins and key ratios below.
What is Bionano Genomics Inc.'s market cap?
Bionano Genomics Inc. (BNGO) has a market capitalization of $6M.
What is the BNGO stock price?
BNGO trades at $1.16.
How much revenue does Bionano Genomics Inc. make?
Bionano Genomics Inc. reported revenue of $29M in fiscal 2025.
Is BNGO profitable?
In fiscal 2025, Bionano Genomics Inc. reported net income of -$26M.